SCHEMBL5064754

SCHEMBL5064754

O=C(O)c1ccc2c(c1)N=C(c1ccc(Cl)cc1)c1cc(F)ccc1S2

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR1 P21554 6/20 0.56
ALDH1A1 P00352 1/20 0.48
RECQL P46063 1/20 0.46
SIRT5 Q9NXA8 1/20 0.46
PLEC Q15149 1/20 0.46
CNR2 P34972 1/20 0.46
RARA P10276 1/20 0.44
RARB P10826 1/20 0.44
RXRA P19793 1/20 0.44
RXRB P28702 1/20 0.44
RXRG P48443 1/20 0.44
MAPT P10636 4/20 0.42
LMNA P02545 2/20 0.41
TP53 P04637 3/20 0.41
POLB P06746 1/20 0.41
SMN1; SMN2 Q16637 2/20 0.40
GAA P10253 1/20 0.40
CDH1 P12830 1/20 0.39
APC P25054 1/20 0.39
CTNNB1 P35222 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5064758 0.90 PLEC (0.55) CNR1ALDH1A1RECQLSIRT5PLEC
SCHEMBL5054116 0.88 CNR1 (0.55) CNR1ALDH1A1RECQLSIRT5PLEC
SCHEMBL5057174 0.84 ALDH1A1 (0.55) CNR1ALDH1A1RECQLSIRT5PLEC
SCHEMBL5062660 0.81 CNR1 (0.80) CNR1ALDH1A1CNR2MAPTLMNA
SCHEMBL13808178 0.80 CNR1 (0.84) CNR1ALDH1A1CNR2MAPTLMNA
SCHEMBL5577088 0.80 CNR1 (0.59) CNR1CNR2MAPTTP53SMN1; SMN2
SCHEMBL5064844 0.77 PLEC (0.67) CNR1ALDH1A1RECQLSIRT5PLEC
SCHEMBL13807776 0.75 CNR1 (0.51) CNR1CNR2MAPTLMNATP53
SCHEMBL5058659 0.75 CNR1 (0.65) CNR1CNR2MAPTTP53SMN1; SMN2
SCHEMBL5062890 0.75 CNR1 (0.84) CNR1CNR2MAPTLMNATP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090805-A1 CB-1 MODULATING COMPOUNDS AND THEIR USE ACADIA PHARMACEUTICALS INC. (US) 2008-04-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080090805-A1 CB-1 MODULATING COMPOUNDS AND THEIR USE CNR1, CNR2, FAAH CNR1 1/4885ALDH1A1 888/4885RECQL 4037/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.